Tourette

Tourette

Alain L Fymat

87,83 €
IVA incluido
Disponible
Editorial:
Tellwell Talent
Año de edición:
2023
ISBN:
9781779410269
87,83 €
IVA incluido
Disponible
Añadir a favoritos

Tourette’s syndrome is a multifaceted disorder that affects 0.6%-1% of the global population. Across their lifespan, affected individuals suffer a worse quality of life than the general population. The hallmarks of the disease are motor and vocal/phonic tics. The severity of the tics is influenced by stressful life events, anxiety, fatigue, and behavioral co-morbidities, more commonly attention-deficit hyperactive disorder and obsessive-compulsive disorder. Although a psychoanalytic etiological view prevailed into the 20th century, the disease is now recognized as a neurodevelopmental motor disorder at the crossroads between neurology, neuropediatrics, and neuropsychiatry. Recent neuroimaging data also suggest a defect in brain maturation. The etiology of the disease is now explained by both genetic factors and, to a lesser extent, environmental influences. While there is no cure, there are a number of medical treatments (including non-medicine behavioral treatments) that can be effective at reducing tics or helping to manage co-occurring conditions. However, there is no one medication that is helpful to all people with Tourette, nor does any medication completely eliminate symptoms. Tics may improve as a result of treatments that include behavioral therapy, pharmacotherapy, and functional neurosurgery (deep brain stimulation, transcranial magnetic stimulation, cranial electrotherapy stimulation, and continuous theta-burst stimulation). If tic symptoms are mild and do not cause impairment, there may be no need for treatment. Treatment is necessary when individuals experience physical discomfort, functional dysfunction, and poor interpersonal interaction and mental health. While Tourette is not life-threatening, tics and their associated co-morbidities affect physical and mental health and their social interactions. While the prognosis has been extensively researched, prognostic indicators carry clinical significance in terms of helping to inform patients of the long-term outcomes of their disorder, and directing their follow-up and management.

Artículos relacionados

Otros libros del autor

  • Memory
    Alain L Fymat
    The history of the brain and the fulcrum of memory can be dated back to humanity’s early history in the 17th century BCE in ancient Egypt, but we still do not comprehend the detailed subtleties of the brain’s functioning in health or disease. Memory, that wonderful but critical property of the brain, refers to the psychological processes of acquiring, retaining, storing, and la...
    Disponible

    147,34 €

  • Memory
    Alain L Fymat
    The history of the brain and the fulcrum of memory can be dated back to humanity’s early history in the 17th century BCE in ancient Egypt, but we still do not comprehend the detailed subtleties of the brain’s functioning in health or disease. Memory, that wonderful but critical property of the brain, refers to the psychological processes of acquiring, retaining, storing, and la...
    Disponible

    133,29 €

  • Tourette
    Alain L Fymat
    Tourette’s syndrome is a multifaceted disorder that affects 0.6%-1% of the global population. Across their lifespan, affected individuals suffer a worse quality of life than the general population. The hallmarks of the disease are motor and vocal/phonic tics. The severity of the tics is influenced by stressful life events, anxiety, fatigue, and behavioral co-morbidities, more c...
    Disponible

    102,72 €

  • Multiple System Atrophy
    Alain L Fymat
    Multiple system atrophy is a rare condition of the nervous system that causes gradual damage to nerve cells in the brain and spinal cord and progressive loss of associated functions. It is a member of a class of neurodegenerative diseases known as synucleinopathies that have in common an abnormal accumulation of the alpha-synuclein protein in various parts of the brain. The hal...
    Disponible

    69,33 €

  • Multiple System Atrophy
    Alain L Fymat
    Multiple system atrophy is a rare condition of the nervous system that causes gradual damage to nerve cells in the brain and spinal cord and progressive loss of associated functions. It is a member of a class of neurodegenerative diseases known as synucleinopathies that have in common an abnormal accumulation of the alpha-synuclein protein in various parts of the brain. The hal...
    Disponible

    84,22 €

  • Multiple Sclerosis
    Alain L Fymat
    Multiple sclerosis (MS) is a chronic debilitating demyelinating disease of the central nervous system. It is caused by an autoimmune attack resulting in the progressive loss of the myelin sheath on neuronal axons. The resultant decrease in the speed of signal transduction leads to a loss of functionality that includes both cognitive and motor impairment depending on the locatio...
    Disponible

    99,36 €